Gemzar®(Ci) and epirubicin (E) in patients (pts) with metastatic breast cancer(MBC):: Final results of a phase I dose finding study

被引：0
|
作者：
Fumoleau, P
Viens, P
Dieras, V
Pujade-Lauraine, E
Espie, M
Kayitalire, L
Rongier, AM
Pouillart, P
机构：
[1] Ctr Rene Gauducheau, F-44035 Nantes, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Inst Curie, Paris, France
[4] Hop St Louis, Paris, France
[5] Hotel Dieu, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1173
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [41] Low dose-intensity docetaxel (D) in pretreated patients (pts) with metastatic breast cancer (MBC).
    Massacesi, C
    Battelli, N
    Mazzanti, P
    Delprete, S
    Pilone, A
    Rossini, S
    Giustini, L
    Battelli, T
    ANNALS OF ONCOLOGY, 2000, 11 : 39 - 39
  • [42] Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: A preliminary report on safety
    Catimel, G
    Spielmann, M
    Dieras, V
    Kayitalire, L
    Pouillart, P
    Guastalla, JP
    SolerMichel, P
    Graffand, N
    Garet, F
    Dumortier, A
    PellaeCosset, B
    Chazard, M
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 24 - 27
  • [43] A phase I study of docetaxel (D) in combination with high dose cyclophosphamide (C) as first line chemotherapy in patients (pts) with metastatic breast carcinoma (MBC)
    Cuvier, C
    Romieux, G
    Culine, S
    Boccara, C
    Espié, M
    Cottu, P
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S329 - S330
  • [44] A randomised study comparing ondansetron (OND) with ondansetron plus dexamethasone (DEX) in patients (PTS) with metastatic breast cancer (MBC) receiving high dose epirubicin (HDE) - Preliminary report
    Giannakakis, T
    Skarlos, D
    Athanasiades, A
    Fountzilas, G
    Bafaloukos, D
    Kosmidis, P
    Nikolaides, K
    Pavlidis, N
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1235 - 1235
  • [45] Gemcitabine plus dose-escalated epirubicin in advanced breast cancer:: results of a phase I study
    Lüftner, D
    Flath, B
    Akrivakis, C
    Hans-Günther, M
    Ohnmacht, U
    Arning, M
    Possinger, K
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (02) : 141 - 146
  • [46] Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study
    Diana Lüftner
    Bernd Flath
    Costa Akrivakis
    Hans-Günther Mergenthaler
    Ute Ohnmacht
    Michael Arning
    Kurt Possinger
    Investigational New Drugs, 1998, 16 : 141 - 146
  • [47] High dose sequential (HDS) cyclophosphamide (C) and epirubicin (E) with peripheral blood stem cell (PBSC) for metastatic breast cancer (MBC): Promising results
    Cottu, PH
    Espie, M
    Extra, JM
    Mignot, L
    Cuvier, C
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 693 - 693
  • [48] PHASE II TRIAL WITH RFS2000 IN PATIENTS (PTS) WITH ADVANCED AND/OR METASTATIC BREAST CANCER (MBC)
    Sorio, R.
    Chollet, P.
    Caponigro, F.
    Carteni, G.
    Sealone, S.
    Crivellari, D.
    Magri, M. D.
    Adank, S. J.
    Veronesi, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 18 - 18
  • [49] HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE (HD-EC) IN ADVANCED BREAST-CANCER - FINAL RESULTS OF A DOSE FINDING STUDY AND PHASE-II TRIAL
    MARSCHNER, N
    NAGEL, GA
    BEYER, JH
    ADLER, M
    AMMON, A
    ONKOLOGIE, 1990, 13 (04): : 272 - 278
  • [50] A phase II trial of docetaxel in patients (PTS) with anthracycline resistant (AR) metastatic breast cancer (MBC)
    Guastalla, JP
    Bonneterre, J
    Fumoleau, P
    Piccart, M
    Tubiana, M
    Chevallier, B
    Nieamann, C
    Alakl, M
    Nichol, A
    Riva, A
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 348 - 348
12345